Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 02 January 2026

Sec. T Cell Biology

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1761559

Correction: Distinct Arnica montana L. extracts modulate human T cell activation in different ways via differential inhibition of NFκB and NFAT pathways

  • 1Section Molecular Immunology, Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany
  • 2Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
  • 3Next Generation Sequencing Core Facility, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
  • 4Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, University of Ulm, Ulm, Germany

A Correction on
Distinct Arnica montana L. extracts modulate human T cell activation in different ways via differential inhibition of NFκB and NFAT pathways

By Berschneider KM, Wetterauer B, Sticht C, Orlik C, Jahraus B, Kirchgessner H, Zuieva A, Wölfl S, Lairikyengbam D, Beier V, Wabnitz G, Wetterauer P, Schmiech M and Samstag Y (2025) Front. Immunol. 16:1655212. doi: 10.3389/fimmu.2025.1655212

There was a mistake in Table 3 as published. The arrow in the first row “Ferm”, last column “NFAT-dependent gene expression” must be dark grey and without brackets, showing a significant effect. The corrected Table 3 appears below.

Table 3
www.frontiersin.org

Table 3. Differential effects of Arnica montana L. extracts, thymol and helenalin on NFkB versus NFAT signaling.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Arnica montana L. extracts, primary human T cells (PBTs), immunomodulation, NFκB, NFAT, thymol, helenalin, LC-MS/MS

Citation: Berschneider KM, Wetterauer B, Sticht C, Orlik C, Jahraus B, Kirchgessner H, Zuieva A, Wölfl S, Lairikyengbam D, Beier V, Wabnitz G, Wetterauer P, Schmiech M and Samstag Y (2026) Correction: Distinct Arnica montana L. extracts modulate human T cell activation in different ways via differential inhibition of NFκB and NFAT pathways. Front. Immunol. 16:1761559. doi: 10.3389/fimmu.2025.1761559

Received: 05 December 2025; Accepted: 15 December 2025; Revised: 05 December 2025;
Published: 02 January 2026.

Edited and reviewed by:

Varun Sasidharan Nair, Italian Institute of Technology (IIT), Italy

Copyright © 2026 Berschneider, Wetterauer, Sticht, Orlik, Jahraus, Kirchgessner, Zuieva, Wölfl, Lairikyengbam, Beier, Wabnitz, Wetterauer, Schmiech and Samstag. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yvonne Samstag, eXZvbm5lLnNhbXN0YWdAdXJ6LnVuaS1oZWlkZWxiZXJnLmRl

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.